Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease (THRIVE)

Incyte

Status: Enrolling

Conditions: cGVHD

Treatments: Other: Non-Interventional

Study type: Observational

Funder types: Industry

Identifiers

NCT05919511

MA-GVHD-401

Details and patient eligibility

About

The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)

Enrollment: 1,500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years inclusive at the time of signing the ICF
• Allogeneic SCT 90 to 180 days prior to enrollment
• Able to comprehend and willing to provide informed consent
• Willing and able to complete participant-assessment questionnaires either alone or with minimal assistance from a caregiver and/or trained site personnel

Exclusion criteria

• There are no exclusion criteria for this study

Trial design

1,500 participants in 1 patient group

At risk for GVHD

Description:

Equal or Greater than 18 years old post alloSCT

Treatment:

Other: Non-Interventional